Teva Halts Studies for Multiple Sclerosis Drug

Teva Pharmaceutical Industries Ltd. and Active Biotech AB recently announced changes to two current drug studies after eight patients suffered “nonfatal cardiovascular events” during  phases 2 and 3 of a… Read More

With Silver, New Types Of Antibiotics Will Be Stronger

Led by James Collins, a team of biomedical engineers at Boston University, discovered silver’s ability to attack bacteria by creating more permeable cell membranes and intervening with the cell metabolism,… Read More